Clinical trial
Effect of InnoSlim® on Blood Sugar and Blood Lipids Regulation in Humans
NCT04201314 is registered in ClinicalTrials.gov with Chung Shan Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of InnoSlim® on Blood Sugar and Blood Lipids Regulation in Humans
- Lead sponsor
- Chung Shan Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 8, 2019
- Completion date
- September 30, 2020
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperlipidemia